Boston Scientific Corporation Financial Ratios — BSX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	3.89	-44.65	-1.8	-1.83	-3.74	5.32	1.51	21.24	41.59	-0.79	6.17	3.76	8.52	9.03	12.6
Return on Assets (%)	2.03	-21.16	-0.72	-0.71	-1.36	1.92	0.56	8.35	18.23	-0.27	3.3	2.16	4.71	4.98	6.98
Return on Capital (%)	3.92	- -	- -	- -	- -	- -	1.05	- -	- -	- -	5.38	3.72	6.47	6.83	9.33
Return on Invested Capital (%)	3.85	- -	- -	- -	- -	- -	1.18	- -	- -	- -	4.54	3.8	6.7	6.79	8.99
Gross Margin (%)	62.86	65.48	67.6	68.55	70	70.15	70.59	70.65	70.37	64.59	68.78	68.81	69.49	68.61	69.01
EBITDA Margin (%)	21.27	-43.94	11.33	5.75	6.5	15.05	23.53	24.43	23.56	10.52	19.28	21.96	24.85	23.12	24.81
Operating Margin (%)	12.96	12.84	12.38	12.22	13.24	15.73	16.92	16.89	16.21	6.9	15.34	16.04	16.97	17.93	19.78
Incremental Operating Margin (%)	1.09	15.28	44.34	7.59	90.72	36.19	32.02	16.52	8.88	128.47	57.72	26.45	24.58	23.33	29.13
Pretax Margin (%)	8.42	-56.66	-3.12	-6.9	-8.69	2.11	10.31	14.48	6.4	-0.8	9.05	9	13.94	13.63	16.86
Profit Margin (%)	5.79	-56.12	-1.69	-1.61	-3.2	4.14	1.15	17.01	43.78	-0.83	8.76	5.5	11.19	11.07	14.44
Net Income to Common Margin (%)	5.79	-56.12	-1.69	-1.61	-3.2	4.14	1.15	17.01	43.78	-1.16	8.29	5.07	11.03	11.07	14.44
Effective Tax Rate (%)	31.31	- -	- -	- -	- -	- -	88.75	- -	- -	- -	3.35	38.83	19.8	19.11	14.56
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.39	- -	- -	0.32	- -	- -
Sustainable Growth Rate (%)	3.89	-44.65	-1.8	-1.83	-3.74	5.32	1.51	21.24	41.59	-0.75	6.17	3.76	8.49	9.03	12.6

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	4,261	4,256	4,240	4,244	5,677	5,484	5,578	7,056	10,277	9,539	9,451	9,282	9,492	10,746	11,436
ST Debt	4	4	3	403	3	64	1,801	2,253	1,416	13	261	20	531	1,778	299
LT Debt	4,257	4,252	4,237	3,841	5,674	5,420	3,777	4,803	8,861	9,526	9,190	9,262	8,961	8,968	11,137
Total Debt/EBITDA	2.63	-1.34	5.24	10.01	11.68	4.35	2.62	2.94	4.06	9.15	4.12	3.33	2.68	2.78	2.3
Net Debt/EBITDA	2.46	-1.27	4.97	8.63	11.02	4.19	2.53	2.88	3.87	7.09	3.11	2.87	2.33	2.64	1.88
Total Debt/EBIT	4.71	-1.1	35.33	-14.1	-20.06	12.27	4.34	4.69	6.77	-119.24	7.88	5.63	4.05	4.13	3.17
Net Debt/EBIT	4.42	-1.05	33.53	-12.15	-18.93	11.83	4.19	4.59	6.44	-92.46	5.95	4.85	3.51	3.92	2.59
EBITDA to Interest Expense	5.77	-12.2	2.5	1.96	1.71	5.42	9.3	9.96	5.35	2.89	6.72	5.93	13.35	12.7	14.27
EBITDA-CapEx/Interest Expense	4.65	-13.15	1.6	0.64	-0.1	3.24	7.33	7.93	4.06	1.44	5.1	4.62	10.34	9.19	11.03
EBIT to Interest Expense	3.52	3.57	2.73	4.18	3.49	5.66	6.69	6.88	3.68	1.89	5.35	4.33	9.12	9.84	11.38
Interest Expense	281	261	324	216	284	233	229	241	473	361	341	470	265	305	349
Common Equity/Total Assets	53.33	40.05	39.46	37.93	34.85	37.21	36.82	41.55	45.4	49.8	51.57	54.12	54.88	55.26	55.49
Long-Term Debt/Equity (%)	37.5	61.89	64.8	59.49	89.78	80.5	53.86	55.04	63.85	62.16	55.29	52.71	45.88	40.76	45.51
Long-Term Debt/Capital (%)	27.26	38.22	39.31	35.89	47.3	44.36	30	30.43	36.69	38.31	35.25	34.49	30.88	27.38	31.02
Long-Term Debt/Total Assets (%)	20	24.79	25.57	22.56	31.29	29.95	19.84	22.87	28.99	30.95	28.51	28.53	25.5	22.76	25.5
Total Debt/Equity (%)	37.53	61.95	64.84	65.73	89.83	81.45	79.55	80.86	74.06	62.24	56.86	52.82	48.6	48.84	46.73
Total Debt/Capital (%)	27.29	38.25	39.34	39.66	47.32	44.89	44.31	44.71	42.55	38.36	36.25	34.56	32.71	32.81	31.85
Total Debt/Total Assets (%)	20.01	24.81	25.59	24.93	31.31	30.31	29.29	33.6	33.62	30.99	29.32	28.59	27.02	27.28	26.19
Net Debt to Equity	35.18	58.94	61.52	56.64	84.78	78.54	76.85	79.19	70.46	48.26	42.9	45.54	42.15	46.38	38.19
Net Debt/Capital (%)	26.02	37.08	38.09	36.16	45.88	43.99	43.45	44.19	40.85	31.98	29.53	30.86	29.24	31.56	27.53
EBITDA	1,621	-3,185	809	424	486	1,262	2,129	2,400	2,529	1,043	2,292	2,785	3,539	3,872	4,981
EBITDA-CapEx	1,306	-3,433	520	139	-27	754	1,679	1,912	1,919	521	1,738	2,173	2,739	2,802	3,851
Operating Income (Loss)	988	931	884	902	990	1,319	1,531	1,659	1,740	684	1,824	2,034	2,417	3,002	3,971

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.15	0.12	0.12	0.21	0.13	0.05	0.03	0.03	0.04	0.47	0.45	0.24	0.18	0.06	0.36
Current Ratio	1.72	1.71	1.65	1.27	1.43	0.9	0.68	0.76	0.97	1.82	1.48	1.51	1.32	1.08	1.62
Quick Ratio	0.84	0.8	0.84	0.62	0.66	0.47	0.31	0.34	0.42	0.89	0.87	0.76	0.63	0.46	0.9
CFO/Avg Current Liab	0.46	0.72	0.62	0.54	0.26	0.39	0.31	0.06	0.36	0.35	0.47	0.38	0.57	0.61	0.77
Common Equity/Total Assets	53.33	40.05	39.46	37.93	34.85	37.21	36.82	41.55	45.4	49.8	51.57	54.12	54.88	55.26	55.49
Long-Term Debt/Equity (%)	37.5	61.89	64.8	59.49	89.78	80.5	53.86	55.04	63.85	62.16	55.29	52.71	45.88	40.76	45.51
Long-Term Debt/Capital (%)	27.26	38.22	39.31	35.89	47.3	44.36	30	30.43	36.69	38.31	35.25	34.49	30.88	27.38	31.02
Long-Term Debt/Total Assets (%)	20	24.79	25.57	22.56	31.29	29.95	19.84	22.87	28.99	30.95	28.51	28.53	25.5	22.76	25.5
Total Debt/Equity (%)	37.53	61.95	64.84	65.73	89.83	81.45	79.55	80.86	74.06	62.24	56.86	52.82	48.6	48.84	46.73
Total Debt/Capital (%)	27.29	38.25	39.34	39.66	47.32	44.89	44.31	44.71	42.55	38.36	36.25	34.56	32.71	32.81	31.85
Total Debt/Total Assets (%)	20.01	24.81	25.59	24.93	31.31	30.31	29.29	33.6	33.62	30.99	29.32	28.59	27.02	27.28	26.19
CFO/Total Liabilities	10.14	12.45	11.06	12.01	5.85	10.4	11.85	2.53	11	9.76	11.98	10.24	16.04	19.75	23.61
CFO/CapEx	3.2	5.16	3.84	4.45	1.35	2.33	3.17	0.64	3.01	2.89	3.38	2.49	3.13	3.21	4.01
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	5.94	5.89	5.66	5.93	6.08	6.11	5.99	6.22	6.25	5.9	7.19	6.77	6.78	7	7.32
Days Sales Outstanding	61.44	62.01	64.49	61.58	60	59.78	60.91	58.63	58.41	61.84	50.8	53.94	53.8	52.16	49.86
Inventory Turnover	3.1	2.76	2.6	2.52	2.29	2.54	2.62	2.57	2.32	2.4	2.51	2.28	2	1.99	2.16
Days Inventory Outstanding	117.65	132.39	140.46	144.91	159.64	143.71	139.43	142.05	157.49	152.34	145.62	160.4	182.75	183.78	168.77
Accounts Payable Turnover	14.82	11.29	9.74	9.33	9.82	7.45	5.7	6.76	8.07	6.22	6.07	5.09	5.5	5.87	6.04
Accounts Payable Turnover Days	24.63	32.34	37.49	39.12	37.16	49.03	64.05	53.99	45.24	58.66	60.08	71.74	66.35	62.17	60.43
Cash Conversion Cycle	154.46	162.06	167.46	167.37	182.47	154.47	136.3	146.69	170.66	155.52	136.33	142.6	170.2	173.77	158.2
Inventory to Cash Days	-56.21	-70.38	-75.98	-83.34	-99.64	-83.93	-78.52	-83.42	-99.07	-90.5	-94.82	-106.47	-128.95	-131.63	-118.91
Inventories	931	884	897	946	1,016	955	1,078	1,166	1,579	1,351	1,610	1,867	2,484	2,810	2,943
Raw Materials	223	216	209	200	208	236	284	306	416	349	452	548	773	819	849
Work In Process	71	70	90	97	102	94	110	100	192	109	128	147	174	193	246
Finished Goods	637	598	598	649	706	625	685	760	971	893	1,029	1,171	1,537	1,798	1,849
Other Inventory	- -	- -	- -	- -	- -	- -	-1	- -	- -	- -	1	1	- -	- -	-1

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	267	207	217	587	319	196	188	146	217	1,734	1,925	928	865	414	1,965
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	248	233	239
+ Total Debt	4,261	4,256	4,240	4,244	5,677	5,484	5,578	7,056	10,277	9,539	9,451	9,282	9,492	10,746	11,436
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Capital	15,614	11,126	10,779	10,701	11,997	12,217	12,590	15,782	24,154	24,865	26,073	26,855	29,022	32,749	35,908
Total Debt/Capital (%)	27.29	38.25	39.34	39.66	47.32	44.89	44.31	44.71	42.55	38.36	36.25	34.56	32.71	32.81	31.85
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	7,622	7,249	7,143	7,380	7,477	8,386	9,048	9,823	10,735	9,913	11,888	12,682	14,240	16,747	20,074
TTM EBITDA	1,621	-3,185	809	424	486	1,262	2,129	2,400	2,529	1,043	2,292	2,785	3,539	3,872	4,981
TTM Operating Income	988	931	884	902	990	1,319	1,531	1,659	1,740	684	1,824	2,034	2,417	3,002	3,971
TTM Cash Flow to Firm	1,201	- -	- -	- -	- -	- -	1,452	- -	- -	- -	2,200	1,814	2,716	3,682	4,832
TTM Free Cash Flow to Firm	886	- -	- -	- -	- -	- -	1,002	- -	- -	- -	1,646	1,202	1,916	2,612	3,702

Multiples (USD)

Valuation Multiples API ChatGPT

No data availableFinancial data will appear here once available

Shares Outstanding	1,449	1,356	1,322	1,327	1,347	1,362	1,373	1,385	1,395	1,417	1,426	1,433	1,466	1,475	1,483
Diluted Weighted Avg Shares	1,519	1,407	1,341	1,348	1,341	1,377	1,393	1,401	1,411	1,417	1,434	1,440	1,464	1,486	1,495
Basic Weighted Avg Shares	1,509	1,407	1,341	1,324	1,341	1,358	1,370	1,381	1,392	1,417	1,422	1,431	1,453	1,472	1,480
Revenue per Share	5.05	5.15	5.33	5.57	5.57	6.18	6.6	7.11	7.71	7	8.36	8.87	9.8	11.38	13.56
EBITDA per Share	1.07	-2.26	0.6	0.32	0.36	0.93	1.55	1.74	1.82	0.74	1.61	1.95	2.44	2.63	3.36
Operating Income per Share	0.65	0.66	0.66	0.68	0.74	0.97	1.12	1.2	1.25	0.48	1.28	1.42	1.66	2.04	2.68
Basic EPS, GAAP	0.29	-2.89	-0.09	-0.09	-0.18	0.26	0.08	1.21	3.38	-0.08	0.69	0.45	1.08	1.26	1.96
Basic EPS from Cont Ops	0.29	-2.89	-0.09	-0.09	-0.18	0.26	0.08	1.21	3.38	-0.06	0.73	0.49	1.1	1.25	1.95
Diluted EPS, GAAP	0.29	-2.89	-0.09	-0.09	-0.18	0.25	0.07	1.19	3.33	-0.08	0.69	0.45	1.07	1.25	1.94
Diluted EPS from Cont Ops	0.29	-2.89	-0.09	-0.09	-0.18	0.25	0.08	1.19	3.33	-0.06	0.73	0.48	1.09	1.24	1.94
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.02	0.04	0.04	0.02	- -	- -
Cash Flow per Share	0.67	0.91	0.83	0.96	0.52	0.87	1.04	0.22	1.32	1.06	1.31	1.07	1.72	2.33	3.06
Free Cash Flow per Basic Share	0.46	0.73	0.61	0.74	0.13	0.5	0.71	-0.13	0.88	0.7	0.93	0.64	1.17	1.61	2.3
Cash & Equivalents per Share	0.18	0.15	0.16	0.44	0.24	0.14	0.14	0.11	0.16	1.22	1.35	0.65	0.59	0.28	1.33
Book Value per Share	7.83	5.07	4.95	4.86	4.69	4.94	5.11	6.3	9.95	10.82	11.66	12.26	13.16	14.76	16.34
Tangible Book Value per Share	-3.37	-3.98	-3.86	-3.8	-4.71	-4.28	-4.24	-4.01	-3	-0.38	-1.04	-0.87	-0.76	-1.36	-0.72

Boston Scientific Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)